Provider perspectives on multilevel barriers to HPV vaccination

References

• Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2017. MMWR. 2018;67(33):9.
   Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Human papillomavirus vaccination-committee opinion. Obstet Gynecol. 2017;704:6.
   Google Scholar
• Centers for Disease Control and Prevention. HPV vaccine recommendations; 2016. https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html.
   Google Scholar
• American Academy of Pediatrics. HPV Vaccine Implementation Guidance; 2017.
   Google Scholar
• Vadaparampil ST, Kahn JA, Salmon D, Lee J-H, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine. 2011;29(47):8634–41. doi:10.1016/j.vaccine.2011.09.006.
   PubMed Web of Science ®Google Scholar
• Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine. 2010;28(4):7. doi:10.1016/j.vaccine.2009.10.133.
   Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2007;56:1–24.
   PubMedGoogle Scholar
• Florida Dept. of Health. School immunization requirements; 2018. http://clay.floridahealth.gov/programs-and-services/clinical-and-nutrition-services/school-health/school-immi-requirements-2015.html.
   Google Scholar
• AAP Committee on Infectious Diseases. Report of the committee on infectious diseases. 31st ed. 2018.
   Google Scholar
• Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older — advisory committee on immunization practices (ACIP), 2012. MMWR. 2012;61(25):468–70.
   PubMedGoogle Scholar
• Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, Zhou C, Robinson JD. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037–46. doi:10.1542/peds.2013-2037.
   PubMed Web of Science ®Google Scholar
• Garbutt J, Dodd S, Walling E, Lee A, Kulka K, Lobb R. Barriers and facilitators to HPV vaccination in primary care practices: A mixed methods study using the consolidated framework for implementation research. BMC Fam Pract. 2018;19(53). doi:10.1186/s12875-018-0787-5.
   PubMed Web of Science ®Google Scholar
• Lake P, Kasting M, Malo T, Giuliano A, Vadaparampil S. An environmental scan to examine stakeholder perspectives on human papillomavirus vaccination: A mixed methods study. Vaccine. 2018;37: 187–194.
   PubMed Web of Science ®Google Scholar
• Kasting ML, Scherr CL, Ali K, Lake P, Malo TL, Johns T, Roetzheim RG, Quinn GP, Vadaparampil ST. Human papillomavirus vaccination training experience among family medicine residents and faculty. Fam Med. 2017;49:9.
   Web of Science ®Google Scholar
• Vadaparampil ST, Malo TL, Sutton SK, Ali KN, Kahn JA, Casler A, Salmon D, Walkosz B, Roetzheim RG, Zimet GD, et al. Missing the target for routine human papillomavirus vaccination: consistent and strong physician recommendations are lacking for 11- to 12-year-old males. Cancer Epidemiol Biomarkers Prev. 2016;25(10):1435–46. doi:10.1158/1055-9965.EPI-15-1294.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015;24:1673–79. doi:10.1158/1055-9965.EPI-15-0326.
   PubMed Web of Science ®Google Scholar
• Quinn GP, Murphy D, Malo TL, Christie J, Vadaparampil ST. A national survey about human papillomavirus vaccination: what we didn’t ask, but physicians wanted us to know. J Pediatr Adolesc Gynecol. 2012;25(4):254–58. doi:10.1016/j.jpag.2012.02.007.
   PubMed Web of Science ®Google Scholar
• Bruno D, Wilson T, Gany F, Aragones A. Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations. Vaccine. 2014;32(33):6. doi:10.1016/j.vaccine.2014.05.058.
   Web of Science ®Google Scholar
• Tom A, Robinett H, Buenconsejo-Lum L, Irizarry J, Rodriguez J, Tang W, Kannaley K. Promoting and providing HPV vaccination in Hawaii: barriers faced by health providers. J Community Health. 2016;41(5):9. doi:10.1007/s10900-016-0183-9.
   Web of Science ®Google Scholar
• Malo TL, Hassani D, Staras SA, Shenkman EA, Giuliano AR, Vadaparampil ST. Do Florida medicaid providers’ barriers to HPV vaccination vary based on VFC program participation? Matern Child Health J. 2013;17(4):609–15. doi:10.1007/s10995-012-1036-5.
   PubMed Web of Science ®Google Scholar
• Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82. doi:10.1001/jamapediatrics.2013.2752.
   PubMed Web of Science ®Google Scholar
• Henrikson N, Tuzzio L, Gilkey M, McRee A. “You’re never really off time”: healthcare providers’ interpretations of optimal timing for HPV vaccination. Prev Med Rep. 2016;16:4.
   Google Scholar
• Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah PD, Brewer NT. Physician communication about adolescent vaccination: how is human papillomavirus vaccine different? Prev Med. 2015;77:181–85. doi:10.1016/j.ypmed.2015.05.024.
   PubMed Web of Science ®Google Scholar
• Staples J, Wong M, Rimel B. An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students. Gynecol Oncol. 2018;149:5.
   Web of Science ®Google Scholar
• Widman C, Rodriguez E, Saad-Harfouche F, Twarozek A, Erwin D, Mahoney M. Clinician and parent perspectives on educational needs for increasing adolescent HPV vaccination. J Cancer Educ. 2018;33(2):8. doi:10.1007/s13187-016-1105-3.
   Web of Science ®Google Scholar
• Grandahl M, Rosenblad A, Stenhammar C, Tydén T, Westerling R, Larsson M, Oscarsson M, Andrae B, Dalianis T, Nevéus T. School-based intervention for the prevention of HPV among adolescents: a cluster randomised controlled study. BMJ Open. 2016;6(1). doi:10.1136/bmjopen-2015-009875.
   PubMed Web of Science ®Google Scholar
• Fu LY, Bonhomme LA, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine. 2014;32(17):1901–20. doi:10.1016/j.vaccine.2014.01.091.
   PubMed Web of Science ®Google Scholar
• Smulian EA, Mitchell KR, Stokley S. Interventions to increase HPV vaccination coverage: A systematic review. Hum Vaccin Immunother. 2016;12(6):1566–88. doi:10.1080/21645515.2015.1125055.
   PubMed Web of Science ®Google Scholar
• Mayne S, Karavite D, Grundmeier RW, Localio R, Feemster K, DeBartolo E, Hughes CC, Fiks AG. The implementation and acceptability of an HPV vaccination decision support system directed at both clinicians and families. AMIA Annu Symp Proc. 2012:616–24.
   PubMedGoogle Scholar
• Healthcare.gov. Preventive care benefits for children. https://www.healthcare.gov/preventive-care-children/.
   Google Scholar
• Centers for Disease Control and Prevention. Resources for adult vaccination insurance and payment; 2016 [ accessed 2018 May 31]. https://www.cdc.gov/vaccines/hcp/adults/for-practice/insurance-payment.html.
   Google Scholar
• Gardasil. Insurance and support: assistance programs; 2017. [ accessed 2018 May 31]. https://www.gardasil9.com/insurance-and-support/assistance-programs/.
   Google Scholar
• Calo W, Gilkey M, Shah P, Moss J, Brewer N. Parents’ support for school-entry requirements for human papillomavirus vaccination: a national study. Cancer Epidemiol Biomarkers Prev. 2016;25(9):9. doi:10.1158/1055-9965.EPI-15-1159.
   Web of Science ®Google Scholar
• Perkins RB, Pierre-Joseph N, Marquez C, Iloka S, Clark JA. Parents’ opinions of mandatory human papillomavirus (HPV) vaccination: does ethnicity matter? Womens Health Issues. 2010;20(6):420–26. doi:10.1016/j.whi.2010.07.001.
   PubMed Web of Science ®Google Scholar
• Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ, Rosenthal SL. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2325–32. doi:10.1158/1055-9965.EPI-09-0184.
   PubMed Web of Science ®Google Scholar
• Tissot AM, Zimet GD, Rosenthal SL, Bernstein D, Wetzel C, Kahn JA. Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health. 2008;41:7.
   Web of Science ®Google Scholar
• Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1):e20161764. doi:10.1542/peds.2016-1764.
   PubMed Web of Science ®Google Scholar
• Kasting ML, Christy SM, Sutton SK, Lake P, Malo TL, Roetzheim RG, Schechtman T, Zimet GD, Walkosz BJ, Salmon D, et al. Florida physicians’ reported use of AFIX-based strategies for human papillomavirus vaccination. Prev Med. 2018;116:143–49. doi:10.1016/j.ypmed.2018.09.004.
   PubMed Web of Science ®Google Scholar